WO2006066583A1 - Procede et dispositif ameliore de determination de motifs de points relatifs a des donnees associees a au moins un etat physiologique d'un utilisateur - Google Patents
Procede et dispositif ameliore de determination de motifs de points relatifs a des donnees associees a au moins un etat physiologique d'un utilisateur Download PDFInfo
- Publication number
- WO2006066583A1 WO2006066583A1 PCT/DK2005/000802 DK2005000802W WO2006066583A1 WO 2006066583 A1 WO2006066583 A1 WO 2006066583A1 DK 2005000802 W DK2005000802 W DK 2005000802W WO 2006066583 A1 WO2006066583 A1 WO 2006066583A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- dates
- representation
- data
- predetermined range
- user
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/74—Details of notification to user or communication with user or patient; User input means
- A61B5/742—Details of notification to user or communication with user or patient; User input means using visual displays
- A61B5/7435—Displaying user selection data, e.g. icons in a graphical user interface
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H20/00—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
- G16H20/10—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients
- G16H20/17—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients delivered via infusion or injection
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H40/00—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices
- G16H40/60—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices
- G16H40/63—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices for local operation
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
- G16H50/70—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for mining of medical data, e.g. analysing previous cases of other patients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue
- A61B5/14532—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue for measuring glucose, e.g. by tissue impedance measurement
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H20/00—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
- G16H20/30—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to physical therapies or activities, e.g. physiotherapy, acupressure or exercising
Definitions
- the present invention relates to the field of self-care of a disease using electronic data analysis devices and methods.
- Chronic diseases and other physiological conditions such as diabetes, asthma, hormone therapy, anti-coagulation treatment, or the like, that require effective therapeutic care over long (or even life-long) periods of time have become a widespread phenomenon. Further characteristics of chronic diseases are often that no permanent cure exists and that the involved clinical picture typically is very complex. Typically, such diseases require medication and/or a control of the patient's lifestyle. Other examples of major chronic diseases are rheumatic diseases, and atherosclerotic heart disease. Diabetes is a classic model disease for chronic diseases and as such the description/examples included is representable for many chonic diseases and as such the invention can readily be transferred from diabetes to many of the chronic diseases.
- Diabetes is one such chronic condition of the human body in which lack of insulin raises the blood sugar levels which in turn has harmful effects that sometimes may even endanger the patient's life.
- a diabetic has to be very careful about the level of blood sugar in his/her body and therefore has to constantly monitor the activities that are likely to have an impact on the same.
- To keep the blood sugar level in check a person with diabetes diabetic has to sometimes take insulin.
- insulin injections These injections have to be administered after considering the patient's present condition as well as carefully predicting the near future state.
- various blood sugar measurement devices such as strips and meters are available in the market.
- the measurement devices have also been combined with insulin administration devices. This way the patient can carry one device that would not only measure his/her disease related parameters but would also assist him/her in administering his/her medicine.
- Such devices are great tools for helping a patient to ensure that he or she is in compliance with a medical regimen.
- the data gathering capabilities of such devices are also a helpful tool for doctors when they are assessing the regimen of a given patient.
- the Modal view also often referred to as Modal day view, basal view, etc.
- the Modal view comprises diary data for several days displayed versus the time thus superimposing many days of data into a single picture or image.
- This allows a user or a doctor to spot patterns in the data where such patterns are representative of habits of a patient/user (forth only denoted user).
- Such patterns could e.g. be that just after 9 o'clock in the morning the blood glucose level (referred to as BGL in the following) usually is too high or the like.
- BGL blood glucose level
- the Modal view can be used to display several types of diary data or parameters of a user like blood glucose measurements and/or administered amount of insulin or medication and/or meal intake and/or alcohol intake and/or physical exercise, etc.
- US Patent application 2002/0193679 A1 discloses a method and system using a Modal view, which is incorporated herein in its entirety by reference.
- the Modal view comprises data entries for several days typically over a couple of weeks or even months some entries for certain days may obscure or hide patterns for other days.
- a Modal view comprising enough data points to enable determination of a pattern may be somewhat overloaded with information. If fewer data entries are included in the Modal view then the problem of not being able to determine any patterns may arise due to the fact that too few entries may be present to ensure that the patterns are detectable.
- a further object is to provide this in an easy and efficient way.
- a device for assisting in determination of a pattern in a data set related to at least one physiological condition (and e.g. associated co-morbidities) of a user, the device comprising: - a memory comprising a set of data elements, each data element of said set representing a user action and a date and time when said user action was performed, and
- processor for graphically displaying a representation of at least a part of said set of data elements on a display, where said part comprises data elements being within a predetermined range of dates, wherein the processor is further adapted to
- Such patterns may e.g. arise from behaviour that arises from sub-optimal patient self-management. These patterns are difficult or almost impossible to identify in paper or electronic logbooks or using typical graphical presentations of data related to a physiological condition.
- Patterns or habits may comprise the typical time of day of certain actions, such as typical meal times, typical times at which the patient measures a physiological parameter such as the blood glucose level, typical times and doses of medication, etc.
- the user action may be any action that has influence on the physiological condition(s) to be controlled. Examples of such actions include meal intakes, medication, such as insulin delivery, measurements of a physiological parameter such as blood glucose level, physical activity, or the like.
- Identifying such habits facilitates the user to follow his/her individual habits in a consistent way, thereby allowing a combination of a tight control of the user's lifestyle while providing a high degree of individual freedom and an increased quality of life.
- user related data such as blood glucose, insulin intake etc.
- the self-management of the patient can be customized to the individual patient's lifestyle while still providing control over the patient's day-to-day activities so that his diabetes can be efficiently managed.
- the observance of the patient's habits and the data recording may be performed by the user himself/herself, thereby increasing the user's independence from health care personnel and, thus, increasing the user's quality of life. Furthermore, the monitoring and data recording by the user increases the possibility of constant observance, thereby improving the quality of the recorded data.
- the user may be the patient, a health care professional or the like.
- the change of said predetermined range is done based on input obtained from a user.
- the change of said predetermined range of dates comprises:
- the change of said predetermined range of dates comprises:
- the change of said predetermined range of dates comprises:
- the user action comprises one or more selected actions from the group of a blood glucose measurement, a measurement of a body parameter from blood, urine and/or the like, a meal intake, alcohol intake, physical exercise, and administering medication.
- the body parameter from blood, urine and/or the like may e.g. be blood glucose, ketones, urine glucose, proteins, lipids, etc.
- blood glucose is used as an example.
- the representation of at least a part of said set of data elements is a Modal view representation.
- the at least one physiological condition comprises a chronic disease.
- the at least one physiological condition comprises diabetes.
- the representation further comprises a calculated mean value and standard deviation bars for each data element.
- the representation comprises data elements for weekdays that have been designated in response to input from a user.
- the representation comprises a part for each weekday where data elements belonging to a specific weekday is displayed at the corresponding part.
- the device is selected from a group of:
- PDA personal digital assistant
- PC personal computer
- the term device may comprise any electronic equipment, such as a suitably programmed programmable device.
- the device may e.g. be a portable or wearable device that can be carried by the user or a stationary pc or the like.
- the device may be a suitably programmed portable computer, such as a handheld computer, a PDA, or the like.
- the device is a suitably programmed mobile telephone, pager, or other mobile communications device.
- the device is a drug administration device, such as an insulin administration device, e.g. an insulin injection device, an insulin inhalator, or the like.
- an insulin administration device e.g. an insulin injection device, an insulin inhalator, or the like.
- the drug deliveries by such a combined device may be recorded directly by the device, thereby allowing the recording of the data without the need for an active user input or data transmission from another device.
- a drug administration device may be capable of storing patient related data such as drug dosage, meal details, blood glucose level etc.
- the device is an insulin measuring device, thereby combining insulin measurements with a reminder system. Consequently, the number of separate devices to be carried by a user is reduced, and the times of day at which the blood glucose is measured may be directly fed into the habit analysis system, thereby reducing the required manual inputs or data transmissions from other devices.
- the device further comprises means
- Speaking could e.g. comprise the speaking of "I have identified the following pattern, which is important" or the like.
- the present invention relates to different aspects including the devices described above and in the following, methods, and computer programs, each yielding one or more of the benefits and advantages described in connection with the above-mentioned devices, and each having one or more embodiments corresponding to the embodiments described in connection with the above-mentioned devices.
- the invention also relates to a method of assisting in determination of a pattern in a data set related to at least one physiological condition of a user, where a set of data elements are stored in a memory and where each data element of said set represents a user action and a date and time when said user action were performed, the method comprising the steps of:
- the invention also relates to a computer readable medium/ a computer program product having stored thereon instructions for causing one or more processing units to execute the method according to the present invention.
- Figure 1 illustrates a graphical representation of a prior art Modal view
- Figure 2a illustrates a graphical representation of a graphical user interface comprising physiological-related data entries/elements according to one embodiment of the present invention
- Figure 2b illustrates the graphical representation of Figure 2a at a later stage
- Figure 3a illustrates a graphical representation of a graphical user interface comprising physiological -related data entries/elements according to another embodiment of the present invention
- Figure 3b illustrates the graphical representation of Figure 3a at a later stage
- Figure 4a illustrates a graphical representation of a graphical user interface comprising physiological -related data entries/elements according to yet another embodiment of the present invention
- Figure 4b illustrates the graphical representation of Figure 4a at a later stage
- Figure 5 illustrates a schematic block diagram of an embodiment of a device according to the present invention
- Figure 6 illustrates a schematic block diagram of an embodiment of a system according to the present invention
- FIG. 7a illustrates another embodiment of the present invention
- FIG. 7b illustrates a further embodiment of the present invention.
- Figure 7c illustrates yet a further embodiment of the present invention.
- FIG. 1 illustrates a graphical representation of a prior art Modal view. Shown is a graphical user interface (GUI) (100) containing a Modal view comprising various blood glucose measurements (101). Further comprised are various amounts of insulin (102) that the user has administered.
- GUI graphical user interface
- the part comprising blood glucose measurements (101 ) has in this embodiment a graphical indication of a preferred or target boundary (103) for blood glucose.
- BGL blood glucose level
- the medical-related data for several days is plotted versus the time of the day that they were obtained, where the time scale spans 24 hours. This helps in identifying possible data patterns (and corresponding habits).
- the data (both BGL and administered insulin) is plotted as a data pair or element comprising the time that the measurement was obtained and the value of the measurement (e.g. mmol/L for BGL; IU for insulin).
- the date of the measurement is typically also stored (although not explicitly shown).
- Such a GUI is useful in assisting a user (e.g. a patient, a health-care professional, a physician, a nurse, etc.) in determining any patterns and in particular non-optimal patterns.
- a user e.g. a patient, a health-care professional, a physician, a nurse, etc.
- the user that this data is for, is a user that quite consistently administers insulin at about 8 o'clock (104) in the morning, which is probably before breakfast.
- this user has quite a lot of BGL values that are too high (e.g. above 12 mmol/L), which signals that there are some habits of the user that should be improved upon.
- the GUI part comprising insulin data (102) may comprise data for different types of insulin (e.g. slow acting and fast acting insulin).
- the different types may as an example be color-coded and/or be indicated by different types of symbols (e.g. '*', '•', ' ⁇ etc.).
- BGL data (101) may also be indicated using color codes and/or various symbols.
- Other types of data like exercise, amount of intake of food or alcohol or the like could also be included and presented in the GUI (100).
- the GUI (100) preferably also comprises various other elements such as descriptive fields comprising relevant information.
- Figure 2a illustrates a graphical representation of a graphical user interface comprising physiological-related data entries or elements according to one embodiment of the present invention.
- GUI graphical user interface
- data elements being within a predetermined range of dates are being displayed.
- the range of dates may be selected by the user using traditional ways such as typing, clicking, using drop-down menus, calendar functionality, etc.
- the user may specify a start date and an end date or a length of the date range/data window.
- the range of the displayed data elements is animated on the display by gradually increasing the range of dates.
- the animation may e.g. step one day at a time, less than one day or several days if preferred.
- the increasing range view increase the number of days that data is displayed by starting at a selected start day (e.g. 1 st July) or a selected number of start days (e.g. all days of July) and continually adding data for days until a target date is met or the user stops or pauses the animation.
- the first view, picture, image, frame or the like would then contain the data of the start day (or start days) and would then be updated with the data from the 2. day, the 3. day and so on until the target date is reached and would now be showing data from the entire selected date range. In effect the time window of the displayed data elements is gradually increased.
- the target date could e.g. be specified as an end date (e.g. 2nd August 2004), as a length in days (e.g. 60 days from the start day(s)).
- the user could also slide back and forth between the date ranges, e.g. using a time slider (105) or the like.
- a single data point e.g. BGL, insulin or both types
- a line is drawn between the various data points of a single day that the selected point belongs to. This helps illustrating which data arises from a single day, which could be useful for disregarding a single bad day (it is important to understand whether several BGL values that is too large is for the same day or whether they are for several days, which could indicate a pattern that needs to be addressed. This also holds for the embodiments described later.
- GUI (100) could comprise only one of the BGL data (101 ) or the insulin data (102) (or the other types of data) just as well as both of them at the same time.
- Figure 2b illustrates the graphical representation of Figure 2a at a later stage. This figure corresponds to the one of Figure 2a but at a later stage where the range according to the present invention has increased, which is also apparent from the time slider (105).
- Figure 3a illustrates a graphical representation of a graphical user interface comprising physiological -related data entries/elements according to another embodiment of the present invention.
- This embodiment of the present invention corresponds to the embodiment of Figures 2a and 2b with the exception that instead of an increasing range a decreasing range is displayed/animated and that whereas the embodiment of Figures 2a and 2b would typically start with data for a single day or several days but would add days then this embodiment would typically start with data for several days where data would gradually be removed.
- the range of the displayed data elements is animated on the display by gradually decreasing the range of dates.
- the animation may e.g. step one day at a time, less than one day or several days if preferred.
- the decreasing range view decrease the number of days that data is displayed for, starting at a selected number of start days (e.g. 1. of July to 1. of December) and continually removing data for days until a target date (e.g. 1. of July) is met or the user stops or pauses the animation. In effect, the time window of the displayed data is gradually decreased.
- start days e.g. 1. of July to 1. of December
- target date e.g. 1. of July
- the first view, picture, image, frame or the like would then contain the data of the start days and would then be updated to not have the data from the last day of the range, not having the data for the two last days of the range, not having the data for the last three days and so on until the target date is reached and would now only be showing data from the first day of the range or from several days in the beginning of the selected date range.
- Figure 3b illustrates the graphical representation of Figure 3a at a later stage. This figure corresponds to the one of Figure 3a but at a later stage where the range according to the present invention has decreased.
- Figure 4a illustrates a graphical representation of a graphical user interface comprising physiological -related data entries/elements according to yet another embodiment of the present invention.
- This embodiment of the present invention corresponds to the embodiments of Figures 2a and 2b and Figures 3a and 3b with the exception that instead of having an increasing or decreasing time window then the time windows is shifted while keeping its length.
- the animation may e.g. step one day at a time, less than one day or several days if preferred.
- This embodiment animates a view of a given length (e.g. 1 month) from a selected start date to a selected end day (or the other way around).
- First data from a first period (e.g. 1 month) is being displayed.
- the time window is moved along e.g. in steps of 1 day to the end date where the data of the last month will be displayed (if the moving time window is 1. month).
- the time window may be moved in both directions.
- Figure 4b illustrates the graphical representation of Figure 4a at a later stage. As can be seen the time window has moved and different data is being displayed. Preferably, several frames have been displayed between the stage of Figure 4a and the stage of Figure 4b.
- one tool could comprises all or just some of the animations of the embodiments of Figures 2a - 4b and could also comprise the embodiments or the functionality of Figures 7a - 7c.
- Figure 5 illustrates a schematic block diagram of an embodiment of a device according to the present invention.
- the device generally designated 301 , comprises a data input unit 302, a processing unit 303 configured to receive the data input via input unit 302, a memory 304 or other storage device connected to the processing unit 303, and an output unit 305 connected to the processing unit 302.
- the data input unit 302 comprises user input means such as push buttons, a keypad, a keyboard, a touch screen, a pointing device, e.g. a computer mouse, a stylus, a mouse pad, or the like, allowing a user to enter data, in particular the data to be recorded for the purpose of the habit detection.
- the input unit further allows the user to select or specify data ranges, start and end dates, etc.
- the input unit 302 may comprise different input means such as a data interface adapted to receive data from other devices, e.g. from a blood glucose measuring device, an insulin administration device, from a data processing device, or the like.
- the data interface may comprise any circuit or device suitable for data communication via a wired or a wireless channel.
- data interfaces include but are not limited to an infrared port, e.g. an IrDa port, a radio-frequency interface such as Bluetooth, a serial port, such as USB, FireWire, or the like.
- the input unit 302 may comprise an internal interface for receiving data from other components within the device 301 , e.g. in an embodiment, where the device 301 comprises both a diabetes self-management device and a blood glucose measuring device and/or an insulin administration device.
- the processing unit 303 may comprise a suitably programmed microprocessor or any other suitable processing means, such as Digital Signal Processors (DSP), Application Specific Integrated Circuits (ASIC), Programmable Logic Arrays (PLA), Field Programmable Gate Arrays (FPGA), special purpose electronic circuits, etc., or a combination thereof.
- DSP Digital Signal Processors
- ASIC Application Specific Integrated Circuits
- PDA Programmable Logic Arrays
- FPGA Field Programmable Gate Arrays
- special purpose electronic circuits etc., or a combination thereof.
- the memory 304 may be any suitable type of memory or storage device, such as a non-volatile memory, e.g. flash memory, EPROM, EEPROM, a hard disk, or the like.
- a non-volatile memory e.g. flash memory, EPROM, EEPROM, a hard disk, or the like.
- the output unit 305 includes any suitable circuit or device for issuing a reminder, e.g. an audible reminder, such as a beep or other sound, a visual reminder, and/or a tactile reminder.
- a reminder e.g. an audible reminder, such as a beep or other sound, a visual reminder, and/or a tactile reminder.
- the output unit may comprise a sound generator, a loudspeaker, an LED or other light source, a display such as and LCD display, a vibrator, etc., or any combination of the above.
- the output unit includes a display that provides a graphical user interface (GUI) for presenting feedback, data elements, etc. to the user and allowing the user to edit them as described herein.
- GUI graphical user interface
- the device described herein may be a special-purpose device or a combined device providing functionality as described herein in combination with an insulin administration device, a blood glucose measurement device or any other device used by a diabetes patient.
- the device may be embodied as a suitably programmed general-purpose data processing device, such as a handheld computer, a PDA, or the like, or a suitably configured/programmed personal communications device, such as a mobile telephone, or the like.
- the process described herein may be implemented by a single device as described above or by a system comprising more than one device.
- the data animation can either be performed on the machine on which the data was entered, or the data can be transferred onto a general purpose computing device that can then perform the said functions.
- the link up of these user device to another computing device allows an improved analysis of the data using the enhanced computational power available as well as sophisticated and specialized software designed for the purpose.
- Various statistical means may be employed to display the patient data for easy understanding as well as accurate and beneficial analysis. For instance, there can be a report which would show the patient's blood glucose level at various times of the day and indicate any undesired highs or lows. Similarly there can be a report for patient's food intake.
- These reports can be textual or various graphical representations such as bar graph, pie chart, histograms etc can be used to facilitate easier understanding of the results.
- Modal day display is one such kind of display in which patient related events that occurred on different days are treated as if they occurred on a single day, thereby providing a compact overview of the patient's daily habitual patterns.
- Algorithms such as the 7 point algorithm for measuring blood glucose may be used for such display. In this algorithm the display is before and after each main meal i.e. breakfast, lunch and dinner and at sleep time.
- Figure 6 illustrates a schematic block diagram of an embodiment of a system according to the present invention.
- the system comprises a device, e.g. a suitably configured drug administration device, generally designated 401 , comprising an input unit 402, a processing unit 403, a memory 404, and an output unit.
- a device e.g. a suitably configured drug administration device, generally designated 401 , comprising an input unit 402, a processing unit 403, a memory 404, and an output unit.
- the device 401 and the above-mentioned components correspond to the device 301 and its corresponding components described in connection with Figure 5 and will therefore not be described again here.
- the device 401 further comprises an interface unit 406 adapted to communicate data with an external data processing system 410.
- the data processing system 410 comprises a corresponding interface unit 412.
- Each of the interface units 406 and 410 may include any suitable circuit or device adapted to provide data communication between the device 401 and the data processing system 410. Examples of interface units include but are not limited to an infrared port, e.g.
- an IrDa port a radio-frequency interface such as Bluetooth, a serial port, such as USB, FireWire, or the like, a local area network (LAN) connection, a wireless local area network (WLAN) connection, an ADSL connection, an ISDN connection or any other Internet connection, a data connection via a cellular telecommunications network, e.g. via GSM, GPRS, UMTS, or the like.
- data may transferred between the device 401 and the data processing system 410 by means of a data carrier, such as a memory stick, a diskette, a smart card, or the like.
- the data processing system 410 further comprises a processing unit 413, a memory or other storage device 414, e.g. as described in connection with the processing unit 303 and the memory 304. Furthermore, the data processing system 410 provides a graphical user interface 416, e.g. via a suitable display and a corresponding input device, such as a keyboard, keypad, pointing device, etc.
- the data processing system 410 may be a suitably programmed conventional computer, e.g. a desktop personal computer (PC), a portable computer, or the like.
- the data entry may be performed via the user device 401 and/or the data processing system 410.
- This arrangement between the device and the data processing system may be a simple one-to-one link between the two entities. However, they may also be part of a patient-doctor-relative-peer network.
- the data processing system may periodically logon to a Local Area Network or Internet, or the like, to transmit the user readings to a remote database server that might be used to generate reports from a different computing system such as that of a doctor, relative of the patient and the like.
- These computing devices can be general-purpose desktops or other variations such as laptop, cell phones, PDAs etc.
- Figure 7a illustrates another embodiment of the present invention. Shown is a GUI (100) where the graphical representation or animation further comprises a calculated mean value and standard deviation bars for each data element in addition to the data shown in Figures 2a - 4b.
- This additional information may be useful when determining patterns.
- Figure 7b illustrates a further embodiment of the present invention. Shown is a GUI (100) where the graphical representation or animation further comprises data elements for weekdays that have been designated in response to input from a user, i.e. a user selects which weekdays (e.g. Mondays and Saturdays) within the range of dates that data is to be displayed for.
- This additional information may be useful when determining patterns. For example, if the user usually perform sports on Mondays and Saturdays this filter is very helpful. Other examples could e.g. be to determine patterns for Fridays and Saturdays where some users may have a different intake of food and/or alcohol.
- Figure 7c illustrates yet a further embodiment of the present invention. Shown is a GUI (100) where the representation or animation further comprises a specific part for each weekday where data elements belonging to a specific weekday is displayed at the corresponding part.
- This additional information may be useful when determining patterns. Especially if the user's patterns or habits is dependent on the specific day, e.g. due to physical exercise, intake of alcohol, etc.
- the method, product means, and device described herein can be implemented by means of hardware comprising several distinct elements, and by means of a suitably programmed microprocessor.
- the features of the method described herein may be implemented in software and carried out on a data processing device or other processing means caused by the execution of program code means such as computer- executable instructions.
- Computer program means or computer program in the present context mean any expression, in any language, code or notation, of a set of instructions intended to cause a system having an information processing capability to perform a particular function either directly or after either or both of the following: a) conversion to another language, code or notation or b) reproduction in a different material form.
- the program may be supplied to the user encoded on a CD-ROM or a floppy disk (both generally depicted by the storage device), or alternatively could be read by the user from the network via a modem device connected to the computer.
- the computer system can load the software from other computer readable media. This may include magnetic tape, a ROM or integrated circuit, a magneto-optical disk, a radio or infra-red transmission channel between the computer and another device, a computer readable card such as a PCMCIA card, and the Internet and Intranets including email transmissions and information recorded on Internet sites and the like.
- the foregoing are merely examples of relevant computer readable media. Other computer readable media may be practiced without departing from the scope and spirit of the invention.
- any reference signs placed between parentheses shall not be constructed as limiting the claim.
- the word "comprising” does not exclude the presence of elements or steps other than those listed in a claim.
- the word 'a" or “an” preceding an element does not exclude the presence of a plurality of such elements.
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Medical Informatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Biomedical Technology (AREA)
- General Health & Medical Sciences (AREA)
- Primary Health Care (AREA)
- Epidemiology (AREA)
- Pathology (AREA)
- Physics & Mathematics (AREA)
- Molecular Biology (AREA)
- Animal Behavior & Ethology (AREA)
- Heart & Thoracic Surgery (AREA)
- Biophysics (AREA)
- Veterinary Medicine (AREA)
- Surgery (AREA)
- Data Mining & Analysis (AREA)
- General Business, Economics & Management (AREA)
- Business, Economics & Management (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Human Computer Interaction (AREA)
- Databases & Information Systems (AREA)
- Measuring And Recording Apparatus For Diagnosis (AREA)
Abstract
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DKPA200401996 | 2004-12-23 | ||
DKPA200401996 | 2004-12-23 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2006066583A1 true WO2006066583A1 (fr) | 2006-06-29 |
Family
ID=36000989
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/DK2005/000802 WO2006066583A1 (fr) | 2004-12-23 | 2005-12-20 | Procede et dispositif ameliore de determination de motifs de points relatifs a des donnees associees a au moins un etat physiologique d'un utilisateur |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO2006066583A1 (fr) |
Cited By (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2008134098A1 (fr) * | 2007-04-25 | 2008-11-06 | Medtronic, Inc. | Affichage graphique des données relatives à des patients |
EP2130152A1 (fr) * | 2006-10-31 | 2009-12-09 | F. Hoffmann-Roche AG | Procédé permettant de traiter une séquence chronologique de mesures d'un paramètre dépendant du temps |
US8688386B2 (en) | 2009-06-30 | 2014-04-01 | Lifescan, Inc. | Analyte testing method and device for calculating basal insulin therapy |
US8974387B2 (en) | 2009-09-29 | 2015-03-10 | Lifescan Scotland Limited | Analyte testing method and device for diabetes management |
US9563743B2 (en) | 2010-02-25 | 2017-02-07 | Lifescan Scotland Limited | Analyte testing method and system with high and low blood glucose trends notification |
US10610624B2 (en) | 2013-03-14 | 2020-04-07 | Smith & Nephew, Inc. | Reduced pressure therapy blockage detection |
US10639502B2 (en) | 2010-10-12 | 2020-05-05 | Smith & Nephew, Inc. | Medical device |
US11315681B2 (en) | 2015-10-07 | 2022-04-26 | Smith & Nephew, Inc. | Reduced pressure therapy device operation and authorization monitoring |
US11369730B2 (en) | 2016-09-29 | 2022-06-28 | Smith & Nephew, Inc. | Construction and protection of components in negative pressure wound therapy systems |
US11602461B2 (en) | 2016-05-13 | 2023-03-14 | Smith & Nephew, Inc. | Automatic wound coupling detection in negative pressure wound therapy systems |
US11712508B2 (en) | 2017-07-10 | 2023-08-01 | Smith & Nephew, Inc. | Systems and methods for directly interacting with communications module of wound therapy apparatus |
US11793924B2 (en) | 2018-12-19 | 2023-10-24 | T.J.Smith And Nephew, Limited | Systems and methods for delivering prescribed wound therapy |
US11974903B2 (en) | 2017-03-07 | 2024-05-07 | Smith & Nephew, Inc. | Reduced pressure therapy systems and methods including an antenna |
US12002566B2 (en) | 2013-03-14 | 2024-06-04 | Smith & Nephew, Inc. | Attachment system for mounting apparatus |
US12090264B2 (en) | 2012-05-22 | 2024-09-17 | Smith & Nephew Plc | Apparatuses and methods for wound therapy |
US12133789B2 (en) | 2014-07-31 | 2024-11-05 | Smith & Nephew, Inc. | Reduced pressure therapy apparatus construction and control |
US12263294B2 (en) | 2016-09-28 | 2025-04-01 | T.J.Smith And Nephew, Limited | Systems and methods for operating negative pressure wound therapy devices |
Citations (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5491781A (en) * | 1993-03-12 | 1996-02-13 | Hewlett-Packard Company | Method and apparatus for displaying a graphic image |
WO2000032088A1 (fr) | 1998-11-30 | 2000-06-08 | Novo Nordisk A/S | Systeme medical et procede de commande d'un systeme utilise par un patient pour s'auto-traiter |
US6322502B1 (en) * | 1996-12-30 | 2001-11-27 | Imd Soft Ltd. | Medical information system |
WO2001093756A2 (fr) * | 2000-06-09 | 2001-12-13 | Nexan Limited | Systeme de telemonitorage portatif pour patient distant utilisant une carte memoire ou une carte a puce |
WO2003005891A1 (fr) | 2001-07-09 | 2003-01-23 | Novo Nordisk A/S | Procede et systeme de controle d'informations de donnees entre deux appareils medicaux portatifs |
WO2003015838A2 (fr) | 2001-08-13 | 2003-02-27 | Novo Nordisk A/S | Dispositif portable et procede permettant de communiquer des donnees medicales |
US6597378B1 (en) * | 2000-01-18 | 2003-07-22 | Seiko Epson Corporation | Display device, portable information processing apparatus, information storage medium, and electronic apparatus |
US20030225315A1 (en) * | 2002-05-31 | 2003-12-04 | Merrett Philip Jonathan | Data analysis system |
US20040102683A1 (en) * | 2002-04-16 | 2004-05-27 | Khanuja Sukhwant Singh | Method and apparatus for remotely monitoring the condition of a patient |
US20040204635A1 (en) * | 2003-04-10 | 2004-10-14 | Scharf Tom D. | Devices and methods for the annotation of physiological data with associated observational data |
-
2005
- 2005-12-20 WO PCT/DK2005/000802 patent/WO2006066583A1/fr not_active Application Discontinuation
Patent Citations (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5491781A (en) * | 1993-03-12 | 1996-02-13 | Hewlett-Packard Company | Method and apparatus for displaying a graphic image |
US6322502B1 (en) * | 1996-12-30 | 2001-11-27 | Imd Soft Ltd. | Medical information system |
WO2000032088A1 (fr) | 1998-11-30 | 2000-06-08 | Novo Nordisk A/S | Systeme medical et procede de commande d'un systeme utilise par un patient pour s'auto-traiter |
US6597378B1 (en) * | 2000-01-18 | 2003-07-22 | Seiko Epson Corporation | Display device, portable information processing apparatus, information storage medium, and electronic apparatus |
WO2001093756A2 (fr) * | 2000-06-09 | 2001-12-13 | Nexan Limited | Systeme de telemonitorage portatif pour patient distant utilisant une carte memoire ou une carte a puce |
WO2003005891A1 (fr) | 2001-07-09 | 2003-01-23 | Novo Nordisk A/S | Procede et systeme de controle d'informations de donnees entre deux appareils medicaux portatifs |
WO2003015838A2 (fr) | 2001-08-13 | 2003-02-27 | Novo Nordisk A/S | Dispositif portable et procede permettant de communiquer des donnees medicales |
US20040102683A1 (en) * | 2002-04-16 | 2004-05-27 | Khanuja Sukhwant Singh | Method and apparatus for remotely monitoring the condition of a patient |
US20030225315A1 (en) * | 2002-05-31 | 2003-12-04 | Merrett Philip Jonathan | Data analysis system |
US20040204635A1 (en) * | 2003-04-10 | 2004-10-14 | Scharf Tom D. | Devices and methods for the annotation of physiological data with associated observational data |
Cited By (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2130152A1 (fr) * | 2006-10-31 | 2009-12-09 | F. Hoffmann-Roche AG | Procédé permettant de traiter une séquence chronologique de mesures d'un paramètre dépendant du temps |
WO2008134098A1 (fr) * | 2007-04-25 | 2008-11-06 | Medtronic, Inc. | Affichage graphique des données relatives à des patients |
US8688386B2 (en) | 2009-06-30 | 2014-04-01 | Lifescan, Inc. | Analyte testing method and device for calculating basal insulin therapy |
US8974387B2 (en) | 2009-09-29 | 2015-03-10 | Lifescan Scotland Limited | Analyte testing method and device for diabetes management |
US9563743B2 (en) | 2010-02-25 | 2017-02-07 | Lifescan Scotland Limited | Analyte testing method and system with high and low blood glucose trends notification |
US11565134B2 (en) | 2010-10-12 | 2023-01-31 | Smith & Nephew, Inc. | Medical device |
US10639502B2 (en) | 2010-10-12 | 2020-05-05 | Smith & Nephew, Inc. | Medical device |
US12090264B2 (en) | 2012-05-22 | 2024-09-17 | Smith & Nephew Plc | Apparatuses and methods for wound therapy |
US10610624B2 (en) | 2013-03-14 | 2020-04-07 | Smith & Nephew, Inc. | Reduced pressure therapy blockage detection |
US10905806B2 (en) | 2013-03-14 | 2021-02-02 | Smith & Nephew, Inc. | Reduced pressure wound therapy control and data communication |
US11633533B2 (en) | 2013-03-14 | 2023-04-25 | Smith & Nephew, Inc. | Control architecture for reduced pressure wound therapy apparatus |
US12002566B2 (en) | 2013-03-14 | 2024-06-04 | Smith & Nephew, Inc. | Attachment system for mounting apparatus |
US12133789B2 (en) | 2014-07-31 | 2024-11-05 | Smith & Nephew, Inc. | Reduced pressure therapy apparatus construction and control |
US11315681B2 (en) | 2015-10-07 | 2022-04-26 | Smith & Nephew, Inc. | Reduced pressure therapy device operation and authorization monitoring |
US11783943B2 (en) | 2015-10-07 | 2023-10-10 | Smith & Nephew, Inc. | Reduced pressure therapy device operation and authorization monitoring |
US11602461B2 (en) | 2016-05-13 | 2023-03-14 | Smith & Nephew, Inc. | Automatic wound coupling detection in negative pressure wound therapy systems |
US12263294B2 (en) | 2016-09-28 | 2025-04-01 | T.J.Smith And Nephew, Limited | Systems and methods for operating negative pressure wound therapy devices |
US11369730B2 (en) | 2016-09-29 | 2022-06-28 | Smith & Nephew, Inc. | Construction and protection of components in negative pressure wound therapy systems |
US11974903B2 (en) | 2017-03-07 | 2024-05-07 | Smith & Nephew, Inc. | Reduced pressure therapy systems and methods including an antenna |
US12083262B2 (en) | 2017-07-10 | 2024-09-10 | Smith & Nephew, Inc. | Systems and methods for directly interacting with communications module of wound therapy apparatus |
US11712508B2 (en) | 2017-07-10 | 2023-08-01 | Smith & Nephew, Inc. | Systems and methods for directly interacting with communications module of wound therapy apparatus |
US11793924B2 (en) | 2018-12-19 | 2023-10-24 | T.J.Smith And Nephew, Limited | Systems and methods for delivering prescribed wound therapy |
US12268806B2 (en) | 2018-12-19 | 2025-04-08 | T.J.Smith And Nephew, Limited | Systems and methods for delivering prescribed wound therapy |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US9501949B2 (en) | Method and system for self-management of a disease | |
WO2006066583A1 (fr) | Procede et dispositif ameliore de determination de motifs de points relatifs a des donnees associees a au moins un etat physiologique d'un utilisateur | |
JP5797224B2 (ja) | 消費者電子デバイスを使用する糖尿病管理のためのコネクタ、システムおよび方法 | |
CN103959291B (zh) | 基于具有自适应选择的核和正则化参数的正则化网络的葡萄糖预测器 | |
US8849458B2 (en) | Collection device with selective display of test results, method and computer program product thereof | |
JP2010508097A (ja) | 時間依存パラメータの測定値の時間的シーケンスを処理する方法 | |
US20080208015A1 (en) | System, apparatus and method for real-time health feedback on a mobile device based on physiological, contextual and self-monitored indicators of mental and physical health states | |
US20100016700A1 (en) | Analyte measurement and management device and associated methods | |
ES2992001T3 (es) | Sistema de monitorización de la diabetes de un paciente con agrupamiento de perfiles de MCG (o perfiles de insulina) diarios no supervisados y procedimiento del mismo | |
WO2009086216A1 (fr) | Procédé et appareil pour fournir une gestion de profil de traitement | |
WO2014037365A1 (fr) | Procédés mis en œuvre par ordinateur permettant de visualiser des corrélations entre des données glycémiques et des événements, et dispositifs associés | |
US20220361823A1 (en) | Wearable blood pressure biosensors, systems and methods for short-term blood pressure prediction | |
KR20150036706A (ko) | 당뇨병이 있는 사람들에 대해 고혈당증 또는 저혈당증을 표시하는 방법 및 시스템 | |
US20160224756A1 (en) | Data management unit for supporting health control | |
US20100331627A1 (en) | Adherence indication tool for chronic disease management and method thereof | |
CA2723352A1 (fr) | Dispositif de mesure et de gestion d'un analyte et procedes associes | |
WO2006066585A2 (fr) | Procede et dispositif destines a la determination amelioree de modeles dans des donnees relatives a au moins un etat physiologique d'un utilisateur | |
US20050149363A1 (en) | Data collection and process control system | |
JP6509232B2 (ja) | データ管理ユニットおよびその動作方法 | |
EP2443577A1 (fr) | Procédés et systèmes destinés à conseiller des personnes diabétiques | |
JP3610949B2 (ja) | 生体情報測定器および生体情報測定システム | |
US20070012322A1 (en) | Method and device for determining a position at which to deliver a substance | |
CN118717103A (zh) | 血糖监测方法、图形界面及相关装置 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KM KN KP KR KZ LC LK LR LS LT LU LV LY MA MD MG MK MN MW MX MZ NA NG NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SM SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): BW GH GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LT LU LV MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 05820918 Country of ref document: EP Kind code of ref document: A1 |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 5820918 Country of ref document: EP |